Neuren Pharmaceuticals | Frais De Vente Et D'Administration



Selling And Administration Expenses Changement Date
Alaunos Therapeutics USD 1.01M 17K 2024-09
Avita Medical AUD 21.23M 2.57M 2024-12
Clinuvel Pharmaceuticals AUD 16.21M 3.62M 2024-06
Dianthus Therapeutics USD 6.83M 287K 2024-12
Ecofibre AUD 8.03M 1.38M 2024-06
Genetic Signatures AUD 9.49M 130K 2024-06
Ionis Pharmaceuticals USD 88.08M 26.44M 2024-12
Medical Developments International AUD 7.07M 15.4M 2024-06
Neuren Pharmaceuticals AUD 2.33M 47K 2024-12
Organon & Co USD 470M 48M 2024-12
Paradigm Biopharmaceuticals AUD 3M 774.85K 2024-06
PYC Therapeutics AUD 1.01M 851.93K 2024-06
Starpharma Holdings AUD 1.82M 1.78M 2024-06
Tectonic Therapeutic USD 4.84M 469K 2024-12
Telix Pharmaceuticals AUD 87.69M 29.72M 2024-06
Viatris USD 882.7M 14.8M 2024-12
Xeris Pharmaceuticals USD 80.28M 35.31M 2024-12



Neuren Pharmaceuticals Frais De Vente Et D'Administration - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.